當(dāng)前位置：首頁 SCI期刊 SCIE期刊醫(yī)學(xué) 中科院4區(qū) JCRQ2 期刊介紹(非官網(wǎng))

Journal Of Human HypertensionSCIE

國際簡稱：J HUM HYPERTENS 參考譯名：人類高血壓雜志

中科院分區(qū)
4區(qū)
CiteScore分區(qū)
Q2
JCR分區(qū)
Q2

基本信息：: ISSN：0950-9240; E-ISSN：1476-5527; 是否OA：未開放; 是否預(yù)警：否; TOP期刊：否

出版信息：: 出版地區(qū)：ENGLAND; 出版商：Springer Nature; 出版語言：English; 出版周期：Monthly; 出版年份：1997; 研究方向：醫(yī)學(xué)-外周血管病

評(píng)價(jià)信息：: 影響因子：2.7; H-index：91; CiteScore指數(shù)：5.2; SJR指數(shù)：0.753; SNIP指數(shù)：0.856

發(fā)文數(shù)據(jù)：: Gold OA文章占比：27.70%; 研究類文章占比：79.10%; 年發(fā)文量：67; 自引率：0.0370...; 開源占比：0.1816; 出版撤稿占比：0; 出版國人文章占比：0.13; OA被引用占比：0.1672...

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡介Journal Of Human Hypertension期刊介紹

Journal of Human Hypertension is published monthly and is of interest to health care professionals who deal with hypertension (specialists, internists, primary care physicians) and public health workers. We believe that our patients benefit from robust scientific data that are based on well conducted clinical trials. We also believe that basic sciences are the foundations on which we build our knowledge of clinical conditions and their management. Towards this end, although we are primarily a clinical based journal, we also welcome suitable basic sciences studies that promote our understanding of human hypertension.

The journal aims to perform the dual role of increasing knowledge in the field of high blood pressure as well as improving the standard of care of patients. The editors will consider for publication all suitable papers dealing directly or indirectly with clinical aspects of hypertension, including but not limited to epidemiology, pathophysiology, therapeutics and basic sciences involving human subjects or tissues. We also consider papers from all specialties such as ophthalmology, cardiology, nephrology, obstetrics and stroke medicine that deal with the various aspects of hypertension and its complications.

期刊簡介Journal Of Human Hypertension期刊介紹

《Journal Of Human Hypertension》自1997出版以來，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個(gè)領(lǐng)域的原創(chuàng)研究提供一個(gè)展示平臺(tái)，以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵(lì)先進(jìn)的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見解，或?qū)彶槎嗄陙砟硞€(gè)重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時(shí)報(bào)道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點(diǎn)：

預(yù)計(jì)審稿時(shí)間：較慢,6-12周
醫(yī)學(xué)
PERIPHERAL VASCULAR DISEASE
SCIE
中科院4區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）Journal Of Human Hypertension Cite Score數(shù)據(jù)

CiteScore：5.2
SJR：0.753
SNIP：0.856

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Internal Medicine	Q2	53 / 167	68%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評(píng)價(jià)期刊影響力的文獻(xiàn)計(jì)量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫中收集的引文為基礎(chǔ)，針對(duì)的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評(píng)價(jià)期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標(biāo)來評(píng)價(jià)。

歷年Cite Score趨勢(shì)圖

中科院SCI分區(qū)Journal Of Human Hypertension 中科院分區(qū)

中科院 2023年12月升級(jí)版 綜述期刊：否 Top期刊：否

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)
醫(yī)學(xué)	4區(qū)	PERIPHERAL VASCULAR DISEASE 外周血管病	4區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運(yùn)用科學(xué)計(jì)量學(xué)方法對(duì)國際、國內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級(jí)劃分的期刊評(píng)價(jià)標(biāo)準(zhǔn)。它為我國科研、教育機(jī)構(gòu)的管理人員、科研工作者提供了一份評(píng)價(jià)國際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國各地高校、科研機(jī)構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個(gè)層次，類似于“優(yōu)、良、及格”等。最開始，這個(gè)分區(qū)只是為了方便圖書管理及圖書情報(bào)領(lǐng)域的研究和期刊評(píng)估。之后中科院分區(qū)逐步發(fā)展成為了一種評(píng)價(jià)學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢(shì)圖

JCR分區(qū)Journal Of Human Hypertension JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：PERIPHERAL VASCULAR DISEASE	SCIE	Q2	34 / 96	65.1%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：PERIPHERAL VASCULAR DISEASE	SCIE	Q2	46 / 96	52.6%

JCR分區(qū)的優(yōu)勢(shì)在于它可以幫助讀者對(duì)學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評(píng)估。不同學(xué)科的文章引用量可能存在較大的差異，此時(shí)單獨(dú)依靠影響因子(IF)評(píng)價(jià)期刊的質(zhì)量可能是存在一定問題的。因此，JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢(shì)圖

發(fā)文數(shù)據(jù)

2023-2024 年國家/地區(qū)發(fā)文量統(tǒng)計(jì)

國家/地區(qū)數(shù)量
England134
CHINA MAINLAND104
USA80
Australia46
Italy33
Scotland23
Japan22
Greece21
India20
Canada18

本刊中國學(xué)者近年發(fā)表論文

1、Association of homocysteine with carotid atherosclerosis in hypertension
Author: Chen, Ai; Wu, Weibin; Gong, Jin; Han, Ying; Xu, Guoyan; Xie, Liangdi

Journal: JOURNAL OF HUMAN HYPERTENSION. 2023; Vol. 37, Issue 3, pp. 227-234. DOI: 10.1038/s41371-022-00665-1
2、The association of arterial stiffness with estimated excretion levels of urinary sodium and potassium and their ratio in Chinese adults
Author: Yang, Qinyu; Jiang, Weihong; He, Yongmei; Yang, Lin; Zhao, Congke; Li, Lijun; Yang, Pingting; Yin, Lu; Li, Xiaohui; Huang, Xin; Li, Ying

Journal: JOURNAL OF HUMAN HYPERTENSION. 2023; Vol. 37, Issue 4, pp. 292-299. DOI: 10.1038/s41371-022-00671-3
3、Left ventricular hypertrophy and incident cognitive decline in older adults with hypertension
Author: Xu, Ying; Bouliotis, George; Beckett, Nigel S.; Antikainen, Riitta L.; Anderson, Craig S.; Bulpitt, Christopher J.; Peters, Ruth

Journal: JOURNAL OF HUMAN HYPERTENSION. 2023; Vol. 37, Issue 4, pp. 307-312. DOI: 10.1038/s41371-022-00681-1
4、Association between perceived stress and hypertension in Chinese adults: a population-based survey
Author: Li, Dianjiang; Rong, Chao; Kang, Qi

Journal: JOURNAL OF HUMAN HYPERTENSION. 2023; Vol. 37, Issue 4, pp. 321-326. DOI: 10.1038/s41371-022-00684-y
5、Association between hypertension and nonalcoholic fatty liver disease: a cross-sectional and meta-analysis study
Author: Huang, Qingzhi; Yu, Hana; Zhong, Xin; Tian, Ying; Cui, Zhenhua; Quan, Zhenyu

Journal: JOURNAL OF HUMAN HYPERTENSION. 2023; Vol. 37, Issue 4, pp. 313-320. DOI: 10.1038/s41371-022-00686-w
6、Comparison of brachial-ankle pulse wave velocity and carotid-femoral pulse wave velocity in association with albuminuria in a community of Beijing: a cross-sectional study
Author: Wang, Ting; Fan, Fangfang; Gong, Yanjun; Gao, Lan; Liu, Zhihao; Jia, Jia; Liu, Mengyuan; Jiang, Yimeng; Zhang, Yan; Li, Jianping

Journal: JOURNAL OF HUMAN HYPERTENSION. 2023; Vol. 37, Issue 5, pp. 412-418. DOI: 10.1038/s41371-022-00697-7
7、Hypokalaemia associated with hydrochlorothiazide used in the treatment of hypertension in NHANES 1999-2018
Author: Lin, Ziying; Li, Hang Long; Tsoi, Man Fung; Cheung, Bernard Man Yung

Journal: JOURNAL OF HUMAN HYPERTENSION. 2023; Vol. 37, Issue 5, pp. 354-362. DOI: 10.1038/s41371-022-00704-x
8、Mediating effect of telomere length in a hypertension population exposed to cadmium: a case-control study
Author: Yang, Qian; Liu, Rujie; Gao, Yuanyuan; Kang, Hui; Zhang, Zhen; Han, Zhichao; Zhang, Yifan; Li, Yuxing; Mu, Lina; Lei, Lijian

Journal: JOURNAL OF HUMAN HYPERTENSION. 2023; Vol. 37, Issue 5, pp. 386-393. DOI: 10.1038/s41371-022-00685-x